FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4234480510> ?p ?o ?g. }

• W4234480510 endingPage "69" @default.
• W4234480510 startingPage "69" @default.
• W4234480510 abstract "Objectives: The goal of this study was to compare daily insulin use, glycemic control, and health care costs in insulin-naive patients with type 2 diabetes who initiated treatment with either insulin detemir or insulin glargine.Methods: This was a retrospective cohort analysis of health care claims data and laboratory results for adult, insulin-naive patients with type 2 diabetes who were enrolled in a large US managed care organization and initiated basal therapy with insulin detemir or insulin glargine between May 1, 2006, and December 31, 2006. The daily average consumption (DACON) of insulin was calculated as the total number of units dispensed (excluding the last fill) divided by the number of days between the index date and the date of the last fill of the index insulin. Glycemic control was evaluated by comparing mean glycosylated hemoglobin (HbA1c) values in the preindex period (the 180 days before the index date) and the follow-up period (the 180 days after the index date). Mean all-cause and diabetes-related health care costs in the preindex and follow-up periods were calculated and compared.Results: The analysis included 48 patients initiating therapy with insulin detemir and 258 initiating therapy with insulin glargine. The mean age of the 2 cohorts was ~54 years, and most patients in each cohort were male (52.1% and 59.7%, respectively). Few patients in either cohort had a baseline HbA1c value <7% (13% and 10%), suggesting poor glycemic control at the time of insulin initiation. After adjustment for confounders (eg, preindex diabetes medication), the DACON of insulin was comparable between cohorts (29.3 and 29.6 U/d; P = NS), as were follow-up HbA1c values (8.2% and 7.9%). Insulin detemir and insulin glargine also were associated with comparable mean adjusted all-cause pharmacy costs ($3074 and $2899), medical costs ($2319 and $3704), and total health care costs ($6014 and $7023). However, insulin glargine was associated with significantly higher mean adjusted diabetes-related medical costs compared with insulin detemir ($1510 vs $707, respectively; P = 0.03), as well as significantly higher mean adjusted total diabetes-related health care costs ($3408 vs $2261; P = 0.03).Conclusions: In this managed care population of insulin-naive patients who initiated therapy with insulin detemir or insulin glargine, the daily insulin dose and glycemic control did not differ significantly between the 2 insulins. However, patients receiving insulin detemir incurred lower diabetes-related medical and total health care costs." @default.
• W4234480510 created "2022-05-12" @default.
• W4234480510 date "1970-01-01" @default.
• W4234480510 modified "2023-09-30" @default.
• W4234480510 title "Magnetostrictive generation of surface elastic waves. (generation of surface waves at 60MHz by magnetostrictive coupling in yttrium iron garnet)" @default.
• W4234480510 doi "https://doi.org/10.1016/0041-624x(70)90968-6" @default.
• W4234480510 hasPublicationYear "1970" @default.
• W4234480510 type Work @default.
• W4234480510 citedByCount "0" @default.
• W4234480510 crossrefType "journal-article" @default.
• W4234480510 hasConcept C126322002 @default.
• W4234480510 hasConcept C134018914 @default.
• W4234480510 hasConcept C167135981 @default.
• W4234480510 hasConcept C2777180221 @default.
• W4234480510 hasConcept C2779306644 @default.
• W4234480510 hasConcept C2779920387 @default.
• W4234480510 hasConcept C2780473172 @default.
• W4234480510 hasConcept C2780668416 @default.
• W4234480510 hasConcept C2780677441 @default.
• W4234480510 hasConcept C555293320 @default.
• W4234480510 hasConcept C71924100 @default.
• W4234480510 hasConcept C72563966 @default.
• W4234480510 hasConceptScore W4234480510C126322002 @default.
• W4234480510 hasConceptScore W4234480510C134018914 @default.
• W4234480510 hasConceptScore W4234480510C167135981 @default.
• W4234480510 hasConceptScore W4234480510C2777180221 @default.
• W4234480510 hasConceptScore W4234480510C2779306644 @default.
• W4234480510 hasConceptScore W4234480510C2779920387 @default.
• W4234480510 hasConceptScore W4234480510C2780473172 @default.
• W4234480510 hasConceptScore W4234480510C2780668416 @default.
• W4234480510 hasConceptScore W4234480510C2780677441 @default.
• W4234480510 hasConceptScore W4234480510C555293320 @default.
• W4234480510 hasConceptScore W4234480510C71924100 @default.
• W4234480510 hasConceptScore W4234480510C72563966 @default.
• W4234480510 hasIssue "1" @default.
• W4234480510 hasLocation W42344805101 @default.
• W4234480510 hasOpenAccess W4234480510 @default.
• W4234480510 hasPrimaryLocation W42344805101 @default.
• W4234480510 hasRelatedWork W2004643446 @default.
• W4234480510 hasRelatedWork W2017030704 @default.
• W4234480510 hasRelatedWork W2020723247 @default.
• W4234480510 hasRelatedWork W2068789151 @default.
• W4234480510 hasRelatedWork W2077148563 @default.
• W4234480510 hasRelatedWork W2165917573 @default.
• W4234480510 hasRelatedWork W2324957922 @default.
• W4234480510 hasRelatedWork W2589876556 @default.
• W4234480510 hasRelatedWork W2775463555 @default.
• W4234480510 hasRelatedWork W2460564906 @default.
• W4234480510 hasVolume "8" @default.
• W4234480510 isParatext "false" @default.
• W4234480510 isRetracted "false" @default.
• W4234480510 workType "article" @default.